Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297224 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Halima Dawood und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases, Coinfection, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NCHHSTP CDC HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Introduction
Hypertension is a leading risk factor for cardiovascular disease among people living with human immunodeficiency virus (PLWH). This study determined incidence and prevalence of hypertension among PLWH receiving antiretroviral therapy (ART).
Method
We prospectively followed-up 642 HIV and tuberculosis (TB) co-infected study participants from 2005–2013. We defined hypertension as two consecutive elevated systolic and/or diastolic blood pressure measurements above 139/89 mmHg or current use of antihypertensive therapy.
Results
Of 507 participants analyzed, 53% were women. Median [interquartile range (IQR)] age, body mass index (BMI), and CD4 count was 34 (28.0–40.0) years, 22.7 (20.5–25.4) kg/m 2 , and 145 (69.0–252.0) cells/mm 3 , respectively. Incidence [95% confidence interval (CI)] of both systolic and diastolic hypertension overall, in men, and in women over 40 years was 1.9 (1.4–2.6), 5.9 (3.6–9.6), and 5.0 (2.7–9.3) per 100 person-years (PY), respectively. Risk of developing hypertension was higher in men [(adjusted hazard ratio (aHR) 12.04, 95% CI: 4.35–33.32)] and women over 40 years (aHR 8.19, 95% CI 2.96–22.64), and in men below 40 years (aHR 2.79, 95% CI 0.95–8.23).
Conclusion
Higher incidence rates of hypertension among older men and women accessing ART highlight opportunities to expand current integrated HIV-TB care models, to include cardiovascular disease risk screening and care to prevent premature death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
- Department of Internal Medicine, Infectious Diseases, Greys Hospital, Pietermaritzburg, South Africa.
- MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Halima Dawood, Upasna Singh
Förderung
- Medical Research Council
- NCHHSTP CDC HHS
- Howard Hughes Medical Institute
- South African Medical Research Council
Zitieren
APA
Dawood, H., Yende-Zuma, N., Singh, U., Moodley, M. C., Ramruthan, J., & Naidoo, K. (2024). Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0297224
Vancouver
Dawood H, Yende-Zuma N, Singh U, Moodley MC, Ramruthan J, Naidoo K. Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0297224
BibTeX
@article{Dawood2024,
author = {Dawood, Halima and Yende-Zuma, Nonhlanhla and Singh, Upasna and Moodley, Mikaila C and Ramruthan, Jenine and Naidoo, Kogieleum},
title = {Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297224}
}
EUVIMED